Project Number 3R01AG056561-02S2 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Neuron regenerative therapeutic, NNI-362, for first-in-human safety and PK for AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) e. Neurogenesis Researcher and Organization Principal Investigator KELLEHER-ANDERSSON, JUDITH A Principal Investigator First Name JUDITH Principal Investigator Last Name KELLEHER-ANDERSSON Awardee Organization NEURONASCENT, INC. Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) FY Overall Cost $246,631 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
